Harvest One Welcomes the Passage of Bill C-45 and the Announced Legalization Date of Cannabis in Canada Cannabis Investing News
Inovio Announces Treatment of First Patient in Immuno-Oncology Study for Glioblastoma (GBM) with INO-5401 in Combination with Regeneron’s PD-1 Inhibitor Biotech Investing
Pacira Pharmaceuticals and Nuance Biotech Announce License Agreement for EXPAREL® in China Pharmaceutical Investing
Fortress Biotech Announces Publication of Phase 1 Data on CNDO-109-Activated Allogeneic Natural Killer Cells in Acute Myeloid Leukemia in Biology of Blood and Marrow Transplantation Biotech Investing
Xanthic Biopharma CEO: Our Business Model Provides Value-add Opportunities for Licensed Producers Cannabis Investing News
Aequus Announces First Canadian Cataract Procedures Using Zepto Capsulotomy System Pharmaceutical Investing
Genentech Announces New OCREVUS (Ocrelizumab) Data on Long-Term Disability Benefits Genetics Investing
FDA Approves Merck’s KEYTRUDA (pembrolizumab) for Treatment of Refractory or Relapsed Primary Mediastinal Large B-Cell Lymphoma Pharmaceutical Investing
